Health authorities have announced an expansion of the meningitis B vaccination programme to include Year 11 pupils at schools impacted by the ongoing outbreak in Kent. This decision comes as new data from the UK Health Security Agency reveals a decline in confirmed cases of the illness.
Latest Case Figures Show Encouraging Trend
As of 12:30 PM on Monday, health officials confirmed 20 cases of meningitis B, with an additional three cases under active investigation, bringing the total to 23. This represents a significant decrease from Sunday's figures, which stood at 29 total cases comprising 20 confirmed and nine under investigation.
Vaccination Programme Expansion
The vaccination initiative initially launched for University of Kent students on Wednesday, March 18. During a campus visit the following day, Health Secretary Wes Streeting announced plans to broaden the programme to include sixth form pupils at four schools with known or suspected meningitis B cases.
Ministers have now approved extending this protection to Year 11 pupils at these same affected schools. UKHSA officials emphasized this precautionary measure aims to ensure longer-term protection against the bacterial infection.
Outbreak Characteristics and Timeline
The UKHSA has released detailed information about the outbreak's progression. Cases have a median age of 19, with the majority occurring among students, though five affected individuals are not currently in education.
Epidemiological investigation reveals that 87% of patients visited Club Chemistry in Canterbury at least once between March 5 and 7 before developing symptoms. The three cases not linked to the nightclub are all University of Kent students residing in halls of residence with connections to attendees.
The earliest confirmed case became unwell on March 9, with the most recent onset occurring on March 16. Health officials identified March 13 as the outbreak's peak, when the highest number of cases were reported.
Scientific Analysis Offers Reassurance
Laboratory analysis conducted by the UKHSA indicates the bacterial strain responsible for the Kent outbreak remains susceptible to both antibiotic treatment and the existing meningitis B vaccine.
Professor Robin May, Chief Scientific Officer at UKHSA, stated: "This preliminary analysis offers strong reassurance that our existing vaccinations and antibiotic treatment offer will be effective against this strain. In collaboration with the research community, we will continue intensive laboratory investigations of the strain to determine how the spread of the outbreak may have been influenced by the bacterial strain, social or environmental conditions, and population immunity."
Clinical Impact and Patient Outcomes
All patients affected by the Kent meningitis outbreak have required hospital admission for treatment. Nine individuals needed intensive care unit support, with four remaining in critical care as of the latest update.
Tragically, the outbreak has claimed two lives: 18-year-old Juliette Kenny, described by her family as "fit, healthy and strong" prior to her illness, and a University of Kent student whose identity has not been publicly disclosed.
The vaccination expansion represents a coordinated public health response to contain the outbreak while providing protection to vulnerable populations. Health officials continue to monitor the situation closely as vaccination efforts progress across educational institutions in the affected region.
